3
|
Anderson KR, Atkinson SLG, Fujiwara T, Giles ME, Matsumoto T, Merifield E, Singleton JT, Saito T, Sotoguchi T, Tornos JA, Way EL. Routes for the Synthesis of (2S)-2-Methyltetrahydropyran-4-one from Simple Optically Pure Building Blocks. Org Process Res Dev 2009. [DOI: 10.1021/op900163a] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Kevin R. Anderson
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - Stéphanie L. G. Atkinson
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - Takahiro Fujiwara
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - Melvyn E. Giles
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - Takaji Matsumoto
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - Eric Merifield
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - John T. Singleton
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - Takao Saito
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - Tsukasa Sotoguchi
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - James A. Tornos
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| | - Edward L. Way
- AstraZeneca R&D Charnwood, Process Research and Development, Bakewell Road, Loughborough, Leicestershire LE11 5RH, United Kingdom, and Takasago International Corporation, Corporate Research and Development Division, 4-11, 1-Chome, Nishi-Yawata, Hiratsuka City, Kanagawa, Japan
| |
Collapse
|